Oct 8, 2019

This episode is the first in a series focusing on recent efforts by the Substance Abuse and Mental Health Services Administration (SAMHSA) to update 42 C.F.R. Part 2 (Part 2) regulations related to the confidentiality of substance use disorder treatment records in light of challenges posed by the opioid epidemic. In...

Mar 27, 2018

In the seventh episode of our series on the national opioid crisis, Erica Jackson discusses efforts by the U.S. Food and Drug Administration (FDA) to address the crisis, while still permitting patient access to effective pain management. Specifically, the episode discusses safety labeling updates, implementation of...

Mar 16, 2018

In the sixth episode of our series on the national opioid crisis, Lauren Perry discusses some of the legal obligations for providers who prescribe controlled substances as treatment for substance abuse disorders.

Specific state and federal requirements will generally vary depending on the type of medication prescribed...

Mar 8, 2018

In the fifth episode of our series on the national opioid crisis, Hilary Bowman discusses the Drug Enforcement Administration’s (DEA) role in regulating individuals and entities handling controlled substances, including opioids. 

Specifically, the episode explains the impact of the Comprehensive Addiction and Recovery...

Mar 1, 2018

In the fourth episode of our series on the national opioid crisis, Ruth Granfors and Tracy Lawless discuss how opioid treatment is reimbursed under Medicaid and other public programs.

Recently, policymakers have considered a variety of solutions for increased funding, such as the availability of Section 1115 waivers of...